1. Home
  2. TARS vs PBH Comparison

TARS vs PBH Comparison

Compare TARS & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$59.11

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Logo Prestige Consumer Healthcare Inc.

PBH

Prestige Consumer Healthcare Inc.

HOLD

Current Price

$49.68

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TARS
PBH
Founded
2016
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.3B
IPO Year
2020
2004

Fundamental Metrics

Financial Performance
Metric
TARS
PBH
Price
$59.11
$49.68
Analyst Decision
Buy
Buy
Analyst Count
6
3
Target Price
$89.00
$75.33
AVG Volume (30 Days)
1.2M
642.2K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
48.21
N/A
EPS
N/A
3.91
Revenue
$451,360,000.00
$975,777,000.00
Revenue This Year
$56.43
N/A
Revenue Next Year
$30.19
$4.31
P/E Ratio
N/A
$12.95
Revenue Growth
146.71
36.77
52 Week Low
$38.51
$42.62
52 Week High
$85.25
$77.45

Technical Indicators

Market Signals
Indicator
TARS
PBH
Relative Strength Index (RSI) 45.93 54.06
Support Level $59.16 $44.86
Resistance Level $67.14 $49.79
Average True Range (ATR) 4.27 1.52
MACD -0.78 0.24
Stochastic Oscillator 31.00 59.78

Price Performance

Historical Comparison
TARS
PBH

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Share on Social Networks: